Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03709563 · ClinicalTrials.gov registry record · NA
Oral Nutraceutical Supplement With Standardized Botanicals in Males With Self-Perceived Thinning Hair and Loss
A NA study, sponsored by DeNova Research.
- Terminated
- Registry status
- NA
- Development phase
- 74
- Enrollment target
NCT03709563: Clinical Trial NA study, sponsored by DeNova Research.
NCT03709563 is a NA study that was terminated before completion, run by DeNova Research. The registered enrollment target is 74 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (95% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03709563, a NA study, was terminated before completion, sponsored by DeNova Research.
- TERMINATED
- Registry status
- NA
- Development phase
- 74 participants
- Enrollment target
Study Summary
Hair loss study in men with self-perceived thinning hair and loss
Primary Outcome
The change in vellus and terminal hair counts / average number of hairs (N/cm2) within 2 ROIs
Interventions
- DIETARY_SUPPLEMENT Placebo
- DIETARY_SUPPLEMENT Oral Nutraceutical Supplement
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 74 participants |
| Start Date | 2018-10-15 |
| Est. Completion | 2021-06-01 |
| Phase | NA |
Why NCT03709563 stopped before completion
NCT03709563 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 74 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (95% lower).
The record links to 0 conditions, and to 2 interventions - of which Placebo is the first listed.
NCT03709563 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT03709563 about?
NCT03709563 is a clinical study titled "Oral Nutraceutical Supplement With Standardized Botanicals in Males With Self-Perceived Thinning Hair and Loss". Hair loss study in men with self-perceived thinning hair and loss
What is the current status of trial NCT03709563?
This trial is currently terminated. It is a NA study. The enrollment target is 74 participants. The study started on 2018-10-15. Estimated completion is 2021-06-01.
What interventions are being tested in trial NCT03709563?
The interventions under investigation include: Placebo (DIETARY_SUPPLEMENT), Oral Nutraceutical Supplement (DIETARY_SUPPLEMENT).
Who is sponsoring clinical trial NCT03709563?
This trial is sponsored by DeNova Research, which has 18 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT03709563's enrollment target sits among peer trials
74 1082nd of 2000 higher than 912 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03422731 · 74 participants · Early Phase 1
Multi-modality Imaging and Collection of Biospecimen Samples in Understanding Bone Marrow Changes in Patients With Acute Myeloid Leukemia Undergoing TBI and Chemotherapy
- NCT03804853 · 74 participants · NA
Rehabilitation Following Reverse Total Shoulder Arthroplasty
- NCT04065776 · 74 participants · NA
Evaluation of Hippocampal-Avoidance Using Proton Therapy in Low-Grade Glioma
- NCT04771156 · 74 participants · Phase 4
Ketorolac in Palatoplasty
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI